Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting.

Willis, Michael; Erntoft, Sandra; Persson, Sofie; Norlin, Jenny M; Persson, Ulf

Willis, Michael; Erntoft, Sandra; Persson, Sofie; Norlin, Jenny M; Persson, Ulf.

Afiliación

Willis M; The Swedish Institute for Health Economics (IHE), Lund, Sweden.
Erntoft S; LEO Pharma A/S, Ballerup, Denmark.
Persson S; The Swedish Institute for Health Economics (IHE), Lund, Sweden; Lund University, Department of Clinical Sciences, Health Economics Unit, Sweden.
Norlin JM; The Swedish Institute for Health Economics (IHE), Lund, Sweden; LEO Pharma A/S, Ballerup, Denmark.
Persson U; The Swedish Institute for Health Economics (IHE), Lund, Sweden; Lund University, Institute for Economic Research, School of Economics, Sweden.

J Health Econ Outcomes Res ; 2(1): 1-14, 2014.

Article en En | MEDLINE | ID: mdl-34430663

Palabras clave

actinic keratosis; contingent valuation; local skin reactions; patient preferences; topical agents; willingness-to-pay

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Health Econ Outcomes Res Año: 2014 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google